BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Kidney tumors

1. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]